A Randomized Phase IIa Trial with Temsirolimus Versus Sunitinib in Advanced Non-Clear Cell Renal Cell Carcinoma: an Intergroup Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and the Interdisciplinary Working Group on Renal Cell Cancer (IAGN) of the German Cancer Society
Oncology Research and Treatment（2020）
Key words
Non-clear cell renal cell cancer,Sunitinib,Temsirolimus,Randomized trial,Phase II trial
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined